Literature DB >> 30447138

Malprogramming of Hepatic Lipid Metabolism due to Excessive Early Cholesterol Exposure in Adult Progeny.

Jerad H Dumolt1, Richard W Browne2, Mulchand S Patel3, Todd C Rideout1.   

Abstract

SCOPE: The programming of hepatic lipid dysfunction in response to early cholesterol exposure and the influencing effects of postnatal diet is evaluated in apoE-/- mice. METHODS AND
RESULTS: In two separate studies, female mice are assigned to a standard chow (S) or a cholesterol-enriched chow (C) diet during gestation and lactation. Male offspring from each dam are weaned on a postnatal S or a hypercaloric western (W) diet resulting in four experimental groups: S-S and C-S (Experiment 1) and S-W and C-W (Experiment 2). At weaning, litters from hypercholesterolemic mothers weighed less (p < 0.05) and pups had higher blood lipids, glucose, and hepatic cholesterol compared with pups from S-fed mothers. Adult C-S offspring demonstrate an atherogenic lipid profile and increased (p < 0.05) hepatic cholesterol and triglyceride content with altered lipid regulatory mRNA expression and protein content compared with S-S offspring. Alternatively, no difference (p > 0.05) is observed between S-W and C-W in serum and hepatic lipid profiles; however, serum AST and ALT are higher (p < 0.05) in C-W versus S-W offspring.
CONCLUSION: The degree of hepatic lipid deposition observed in adult offspring exposed to excessive early cholesterol is influenced by the postnatal diet.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  NAFLD; adult offspring; developmental programming; maternal hypercholesterolemia

Mesh:

Substances:

Year:  2018        PMID: 30447138      PMCID: PMC6362455          DOI: 10.1002/mnfr.201800563

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  54 in total

1.  Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study.

Authors:  Michael M Mendelson; Asya Lyass; Christopher J O'Donnell; Ralph B D'Agostino; Daniel Levy
Journal:  JAMA Cardiol       Date:  2016-04-01       Impact factor: 14.676

2.  Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.

Authors:  Kengo Tomita; Toshiaki Teratani; Takahiro Suzuki; Motonori Shimizu; Hirokazu Sato; Kazuyuki Narimatsu; Yoshikiyo Okada; Chie Kurihara; Rie Irie; Hirokazu Yokoyama; Katsuyoshi Shimamura; Shingo Usui; Hirotoshi Ebinuma; Hidetsugu Saito; Chikako Watanabe; Shunsuke Komoto; Atsushi Kawaguchi; Shigeaki Nagao; Kazuo Sugiyama; Ryota Hokari; Takanori Kanai; Soichiro Miura; Toshifumi Hibi
Journal:  Hepatology       Date:  2013-11-18       Impact factor: 17.425

3.  Maternal hypercholesterolemia in pregnancy associates with umbilical vein endothelial dysfunction: role of endothelial nitric oxide synthase and arginase II.

Authors:  Andrea Leiva; Camila Diez de Medina; Rocío Salsoso; Tamara Sáez; Sebastián San Martín; Fernando Abarzúa; Marcelo Farías; Enrique Guzmán-Gutiérrez; Fabián Pardo; Luis Sobrevia
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-15       Impact factor: 8.311

4.  Guar gum consumption increases hepatic nuclear SREBP2 and LDL receptor expression in pigs fed an atherogenic diet.

Authors:  Todd C Rideout; Zongfei Yuan; Marica Bakovic; Qiang Liu; Ren-Ke Li; Yoshinori Mine; Ming Z Fan
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

Review 5.  The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis.

Authors:  Wulf Palinski; Claudio Napoli
Journal:  FASEB J       Date:  2002-09       Impact factor: 5.191

6.  Early pregnancy lipid concentrations and spontaneous preterm birth.

Authors:  Janet M Catov; Lisa M Bodnar; Kevin E Kip; Carl Hubel; Roberta B Ness; Gail Harger; James M Roberts
Journal:  Am J Obstet Gynecol       Date:  2007-12       Impact factor: 8.661

7.  Developmental Programming: Priming Disease Susceptibility for Subsequent Generations.

Authors:  L C Messer; J Boone-Heinonen; L Mponwane; L Wallack; K L Thornburg
Journal:  Curr Epidemiol Rep       Date:  2015-03-01

8.  Influence of maternal hypercholesterolemia and phytosterol intervention during gestation and lactation on dyslipidemia and hepatic lipid metabolism in offspring of Syrian golden hamsters.

Authors:  Jie Liu; Aadil Iqbal; Amy Raslawsky; Richard W Browne; Mulchand S Patel; Todd C Rideout
Journal:  Mol Nutr Food Res       Date:  2016-06-23       Impact factor: 5.914

9.  Metabolic profile in early pregnancy is associated with offspring adiposity at 4 years of age: the Rhea pregnancy cohort Crete, Greece.

Authors:  Vasiliki Daraki; Vaggelis Georgiou; Stathis Papavasiliou; Georgia Chalkiadaki; Marianna Karahaliou; Stella Koinaki; Katerina Sarri; Maria Vassilaki; Manolis Kogevinas; Leda Chatzi
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

10.  An independent effect of parental lipids on the offspring lipid levels in a cohort of adolescents with type 1 diabetes.

Authors:  M Loredana Marcovecchio; Paivi H Tossavainen; James Jn Heywood; R Neil Dalton; David B Dunger
Journal:  Pediatr Diabetes       Date:  2012-02-27       Impact factor: 4.866

View more
  3 in total

1.  Maternal hypercholesterolemia programs dyslipidemia in adult male mouse progeny.

Authors:  Joyce Mathew; Sze-Chi Huang; Jerad H Dumolt; Mulchand S Patel; Todd C Rideout
Journal:  Reproduction       Date:  2020-07       Impact factor: 3.906

2.  Gestational hypercholesterolemia alters fetal hepatic lipid metabolism and microRNA expression in Apo-E-deficient mice.

Authors:  Jerad H Dumolt; Min Ma; Joyce Mathew; Mulchand S Patel; Todd C Rideout
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-08-27       Impact factor: 4.310

Review 3.  Excessive early-life cholesterol exposure may have later-life consequences for nonalcoholic fatty liver disease.

Authors:  Jerad H Dumolt; Mulchand S Patel; Todd C Rideout
Journal:  J Dev Orig Health Dis       Date:  2020-04-15       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.